SWOG
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1956-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.swog.org
S0410 Tandem Stem Cell Transplantation in Treating Patients With Progressive or Recurrent Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- Procedure: autologous-autologous tandem hematopoietic stem cell transplantationRadiation: radiation therapy
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2018-03-01
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 98
- Registration Number
- NCT00233987
- Locations
- 🇺🇸
Cancer Center of Kansas, PA - Wellington, Wellington, Kansas, United States
🇺🇸Associates in Womens Health, PA - North Review, Wichita, Kansas, United States
🇺🇸Cancer Center of Kansas, PA - Parsons, Parsons, Kansas, United States
S0353, Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
- First Posted Date
- 2005-10-06
- Last Posted Date
- 2016-01-08
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 58
- Registration Number
- NCT00234039
- Locations
- 🇺🇸
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
🇺🇸CCOP - Montana Cancer Consortium, Billings, Montana, United States
🇺🇸Kalispell Regional Medical Center, Kalispell, Montana, United States
S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission
- Conditions
- Breast Cancer
- First Posted Date
- 2005-09-28
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00227474
S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2013-01-03
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00217659
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
🇺🇸Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah, Georgia, United States
🇺🇸Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, United States
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
- Conditions
- Prostate CancerMetastatic Cancer
- Interventions
- First Posted Date
- 2005-08-24
- Last Posted Date
- 2021-10-27
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 1038
- Registration Number
- NCT00134056
- Locations
- 🇺🇸
Saint Joseph's Hospital of Atlanta, Atlanta, Georgia, United States
🇺🇸Northside Hospital Cancer Center, Atlanta, Georgia, United States
🇺🇸CCOP - Atlanta Regional, Atlanta, Georgia, United States
S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2005-08-05
- Last Posted Date
- 2021-07-02
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 6097
- Registration Number
- NCT00127205
S0417 Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2005-07-28
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 7
- Registration Number
- NCT00124579
- Locations
- 🇺🇸
Good Samaritan Regional Health Center, Mount Vernon, Illinois, United States
🇺🇸Providence Cancer Institute at Providence Hospital - Southfield Campus, Southfield, Michigan, United States
🇺🇸St. James Healthcare Cancer Care, Butte, Montana, United States
S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma
- Conditions
- Lymphoma
- Interventions
- Procedure: allogeneic bone marrow transplantationProcedure: peripheral blood stem cell transplantation
- First Posted Date
- 2005-07-21
- Last Posted Date
- 2012-04-03
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 1
- Registration Number
- NCT00121186
- Locations
- 🇺🇸
Cancer Center of Kansas, PA - Dodge City, Dodge City, Kansas, United States
🇺🇸Cancer Center of Kansas, PA - Medical Arts Tower, Wichita, Kansas, United States
🇺🇸Cancer Center of Kansas, PA - Pratt, Pratt, Kansas, United States
S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer
- Conditions
- Colorectal CancerMetastatic Cancer
- Interventions
- First Posted Date
- 2005-07-11
- Last Posted Date
- 2013-01-03
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00118105
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
🇺🇸Rush-Copley Cancer Care Center, Aurora, Illinois, United States
🇺🇸Cancer Research Center at Boston Medical Center, Boston, Massachusetts, United States
S0414 Cetuximab, Combo Chemo, and RT in Locally Advanced Esophageal Cancer
- Conditions
- Esophageal Cancer
- Interventions
- First Posted Date
- 2005-05-04
- Last Posted Date
- 2015-11-18
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 22
- Registration Number
- NCT00109850
- Locations
- 🇺🇸
Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center, Kingsport, Tennessee, United States
🇺🇸Augusta Oncology Associates - Walton Way, Augusta, Georgia, United States
🇺🇸Mobile Infirmary Medical Center, Mobile, Alabama, United States